James Edward Ackroyd

Person

Abingdon, GB

People

Patents Grantslast 30 patents

Information Patent Grant
CRTAM antibodies and methods of treating cancer
- Patent number 11,673,963
- Issue date Jun 13, 2023
- Oxford BioTherapeutics Ltd.
- Arnima Bisht
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Conjugated antibodies against LY75 for the treatment of cancer
- Patent number 10,081,682
- Issue date Sep 25, 2018
- Oxford Bio Therapeutics Ltd.
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
CRTAM ANTIBODIES AND METHODS OF TREATING CANCER
- Publication number 20240228649
- Publication date Jul 11, 2024
- Oxford BioTherapeutics Ltd
- Arnima BISHT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRTAM ANTIBODIES AND METHODS OF TREATING CANCER
- Publication number 20240132614
- Publication date Apr 25, 2024
- Oxford BioTherapeutics Ltd
- Arnima BISHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AND METHODS OF USE
- Publication number 20220372137
- Publication date Nov 24, 2022
- OXFORD BIOTHERAPEUTICS LTD
- Arnima BISHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CONJUGATED ANTIBOIDES AGAINST LY75 FOR THE TREATMENT OF CANCER
- Publication number 20210371541
- Publication date Dec 2, 2021
- OXFORD BIOTHERAPEUTICS LTD
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET
- Publication number 20210346512
- Publication date Nov 11, 2021
- OXFORD BIOTHERAPEUTICS LTD
- James E. Ackroyd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AND METHODS OF USE
- Publication number 20200262927
- Publication date Aug 20, 2020
- OXFORD BIOTHERAPEUTICS LTD
- Arnima BISHT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET
- Publication number 20190317100
- Publication date Oct 17, 2019
- OXFORD BIOTHERAPEUTICS LTD
- James E. Ackroyd
- G01 - MEASURING TESTING
Information Patent Application
CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER
- Publication number 20190106506
- Publication date Apr 11, 2019
- OXFORD BIOTHERAPEUTICS LTD
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Conjugated Antibodies Against LY75 for the Treatment of Cancer
- Publication number 20160257760
- Publication date Sep 8, 2016
- OXFORD BIOTHERAPEUTICS LTD
- Jonathan Alexander Terrett
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INACTIVE N-ACETYLATED-ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE PROTEIN...
- Publication number 20160002351
- Publication date Jan 7, 2016
- Oxford BioTherapeutics Limited
- Lindsey Jane HUDSON
- G01 - MEASURING TESTING
Information Patent Application
LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET
- Publication number 20150297743
- Publication date Oct 22, 2015
- James E. Ackroyd
- G01 - MEASURING TESTING
Information Patent Application
THERAPEUTIC AND DIAGNOSTIC TARGET
- Publication number 20150210770
- Publication date Jul 30, 2015
- OXFORD BIOTHERAPEUTICS LTD
- James Edward Ackroyd
- G01 - MEASURING TESTING

James Edward Ackroyd

Person

Patents Grantslast 30 patents

CRTAM antibodies and methods of treating cancer

Conjugated antibodies against LY75 for the treatment of cancer

Patents Applicationslast 30 patents

CRTAM ANTIBODIES AND METHODS OF TREATING CANCER

CRTAM ANTIBODIES AND METHODS OF TREATING CANCER

ANTIBODIES AND METHODS OF USE

CONJUGATED ANTIBOIDES AGAINST LY75 FOR THE TREATMENT OF CANCER

LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET

ANTIBODIES AND METHODS OF USE

LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET

CONJUGATED ANTIBODIES AGAINST LY75 FOR THE TREATMENT OF CANCER

Conjugated Antibodies Against LY75 for the Treatment of Cancer

INACTIVE N-ACETYLATED-ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE PROTEIN...

LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET

THERAPEUTIC AND DIAGNOSTIC TARGET